Nothing Special   »   [go: up one dir, main page]

MXPA03003855A - Metodo de diagnosis para encefalopatia espongiforme transmisible. - Google Patents

Metodo de diagnosis para encefalopatia espongiforme transmisible.

Info

Publication number
MXPA03003855A
MXPA03003855A MXPA03003855A MXPA03003855A MXPA03003855A MX PA03003855 A MXPA03003855 A MX PA03003855A MX PA03003855 A MXPA03003855 A MX PA03003855A MX PA03003855 A MXPA03003855 A MX PA03003855A MX PA03003855 A MXPA03003855 A MX PA03003855A
Authority
MX
Mexico
Prior art keywords
animal
diagnostic method
sample
megakaryocyte
tse
Prior art date
Application number
MXPA03003855A
Other languages
English (en)
Inventor
Michael Clinton
Original Assignee
Roslin Inst Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roslin Inst Edinburgh filed Critical Roslin Inst Edinburgh
Publication of MXPA03003855A publication Critical patent/MXPA03003855A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporciona un metodo para la diagnosis de una encefalopatia espongiforme transmisible (TSE) o una enfermedad prion e n un animal que comprende analizar una muestra obtenida del animal para determinar la cantidad de celulas hematopoyeticas de los linajes celulares de eritroides, megacariocitos o plaquetas en la muestra o un producto de expresion de la misma.
MXPA03003855A 2000-10-31 2001-10-29 Metodo de diagnosis para encefalopatia espongiforme transmisible. MXPA03003855A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0026604.9A GB0026604D0 (en) 2000-10-31 2000-10-31 Diagnostic method
PCT/GB2001/004806 WO2002037119A2 (en) 2000-10-31 2001-10-29 Method of diagnosing a transmissible spongiform encephalopathy

Publications (1)

Publication Number Publication Date
MXPA03003855A true MXPA03003855A (es) 2004-04-20

Family

ID=9902283

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003855A MXPA03003855A (es) 2000-10-31 2001-10-29 Metodo de diagnosis para encefalopatia espongiforme transmisible.

Country Status (16)

Country Link
US (2) US6962787B2 (es)
EP (1) EP1348128A2 (es)
JP (1) JP2004513347A (es)
KR (1) KR20030053522A (es)
CN (1) CN1473272A (es)
AU (2) AU2002210740B2 (es)
BR (1) BR0115090A (es)
CA (1) CA2427004A1 (es)
GB (1) GB0026604D0 (es)
IL (1) IL155614A0 (es)
MX (1) MXPA03003855A (es)
NO (1) NO20031941L (es)
NZ (1) NZ525905A (es)
RU (1) RU2313790C2 (es)
WO (1) WO2002037119A2 (es)
ZA (1) ZA200303066B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2211181A1 (en) * 2002-10-30 2010-07-28 Proteome Sciences Plc Diagnostic method for transmissible spongiform encephalopathies
DE10261529A1 (de) * 2002-12-23 2004-07-08 Indivumed Gmbh Verfahren zur Erstellung einer Sammlung von biologischem Probenmaterial und Probensammlung
GB0426859D0 (en) * 2004-12-07 2005-01-12 Proteome Sciences Plc Diagnosis of neurodegenerative disorders
WO2011027966A2 (en) * 2009-09-03 2011-03-10 Seegene, Inc. Td probe and its uses
US20140370525A1 (en) * 2011-10-18 2014-12-18 The Children's Hospital Of Philadelphia Alpha-hemoglobin stabilizing protein antibodies and methods of use thereof
RU2475745C1 (ru) * 2012-04-10 2013-02-20 Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук Способ прогнозирования желудочно-кишечных заболеваний с синдромом диареи у новорожденных телят
CN105738614B (zh) * 2016-02-23 2017-12-05 山东大学 一种应用流式细胞仪分析评价小鼠骨髓红细胞生成功能的方法
CN113235940B (zh) * 2021-06-09 2024-08-02 中国水利水电第七工程局有限公司 一种一体化便捷式钢筋间距快速标点辅助工具
CN113235930B (zh) * 2021-06-09 2024-08-02 中国水利水电第七工程局有限公司 一种快速钢筋间距标点的辅助工具

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874301A (en) * 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
JP2002534112A (ja) * 1999-01-15 2002-10-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 骨髄特異的タンパク質
DE19918141A1 (de) 1999-04-21 2000-10-26 Boehringer Ingelheim Vetmed Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien
EP1214337A2 (en) 1999-09-15 2002-06-19 Incyte Genomics, Inc. Proteins associated with cell differentiation

Also Published As

Publication number Publication date
RU2313790C2 (ru) 2007-12-27
NZ525905A (en) 2004-08-27
US20020164661A1 (en) 2002-11-07
NO20031941D0 (no) 2003-04-29
WO2002037119A3 (en) 2003-01-16
AU1074002A (en) 2002-05-15
WO2002037119A2 (en) 2002-05-10
NO20031941L (no) 2003-06-27
US20060051813A1 (en) 2006-03-09
BR0115090A (pt) 2003-10-07
JP2004513347A (ja) 2004-04-30
CN1473272A (zh) 2004-02-04
US7413865B2 (en) 2008-08-19
IL155614A0 (en) 2003-11-23
KR20030053522A (ko) 2003-06-28
EP1348128A2 (en) 2003-10-01
ZA200303066B (en) 2004-07-19
GB0026604D0 (en) 2000-12-13
US6962787B2 (en) 2005-11-08
CA2427004A1 (en) 2002-05-10
AU2002210740B2 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
Montoya et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell‐clonotypic monoclonal antibody, 6B11
Higgins et al. The 5-HT 2A receptor antagonist M100, 907 attenuates motor and'impulsive-type'behaviours produced by NMDA receptor antagonism
Wilkinson et al. Haematopoietic stem cell self-renewal in vivo and ex vivo
Heinonen et al. Wnt4 enhances murine hematopoietic progenitor cell expansion through a planar cell polarity-like pathway
Sakamoto et al. Hydrogen peroxide produced by superoxide dismutase SOD-2 activates sperm in Caenorhabditis elegans
Wood et al. NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle
Bryceson et al. Functional analysis of human NK cells by flow cytometry
Caci et al. Impulsivity but not venturesomeness is related to morningness
MXPA03003855A (es) Metodo de diagnosis para encefalopatia espongiforme transmisible.
BR0308919A (pt) Células-tronco programáveis, desdiferenciadas de origem monocìtica, e sua produção e uso
Behari et al. Role of platelets in neurodegenerative diseases: a universal pathophysiology
Olsson Adolescent Depression: Epidemiology, Nosology, Life Stress and Social Network Minireview based on a doctoral thesis
BR9914648A (pt) Processo para monitorar ação medicamentosa deinibidor de proteasoma
Elsheikh et al. Drug antigenicity, immunogenicity, and costimulatory signaling: evidence for formation of a functional antigen through immune cell metabolism
IN2015DN03125A (es)
EP3546939A3 (en) An assay for measuring cell-mediated immunoresponsiveness
Heimpel Drug-induced agranulocytosis
Hammond et al. Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells
Montecino‐Rodriguez et al. The layered development of mouse B and T Cells
James et al. Angiotensin II activates the GFAT promoter in mesangial cells
DK0974056T3 (da) Prænatale in vitro-diagnostiske fremgangsmåder
Lampl et al. Infants thinner at birth exhibit smaller kidneys for their size in late gestation in a sample of fetuses with appropriate growth
Cuzzolaro et al. Body uneasiness test
Bilici et al. The influence of olanzapine on immune cells in patients with schizophrenia
Ratliff et al. Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells

Legal Events

Date Code Title Description
FG Grant or registration